Observational study / 2017
The gut-derived dietary metabolite TMAO was detected in human cerebrospinal fluid, with no significant differences found among neurological diagnoses.
Researchers evaluated whether the gut microbial metabolite trimethylamine-N-oxide (TMAO) is detectable in human cerebrospinal fluid (CSF) collected from 58 subjects via lumbar puncture. TMAO was detected in all samples, with concentrations ranging from 0.11 to 6.43 µmol/L. Among the participants, 22 had Alzheimer's disease, 16 had non-Alzheimer's dementia, and 20 had other neurological disorders, but stratification of TMAO levels showed no significant differences among these three groups.
Shows an association, not proof of cause and effect.
- Study type
- Cross-sectional analysis
- Who was studied
- 58 human subjects undergoing lumbar puncture for diagnostic purposes
- What was measured
- TMAO concentrations in cerebrospinal fluid
THE PAPER
The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid.
Del Rio D, Zimetti F, Caffarra P, Tassotti M, Bernini F, Brighenti F, Zini A, Zanotti I. Nutrients, 2017.
PubMed 28937600 ↗DOI 10.1146/annurev.pharmtox.46.120604.141043 ↗
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.